HutchMED (China) LIMITED (HMDCF) Capital expenditures 2016–2025
HutchMED (China) LIMITED (HMDCF) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$14.1MFY2025 · since FY2016: $4.3M → $14.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $14.1M | -21.1% |
| FY2024 | $17.9M | -45.0% |
| FY2023 | $32.6M | -11.1% |
| FY2022 | $36.7M | +123.5% |
| FY2021 | $16.4M | +106.3% |
| FY2020 | $7.9M | -7.2% |
| FY2019 | $8.6M | +34.6% |
| FY2018 | $6.4M | +26.8% |
| FY2017 | $5.0M | +16.0% |
| FY2016 | $4.3M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More HMDCF financial trends
HMDCF RevenueHMDCF Net incomeHMDCF Net marginHMDCF Gross profitHMDCF Gross marginHMDCF Operating incomeHMDCF Operating marginHMDCF Operating cash flowHMDCF Free cash flowHMDCF Return on equityHMDCF Stock buybacksHMDCF Dividends paidHMDCF Total assetsHMDCF Total liabilitiesHMDCF Shareholders’ equityHMDCF overview →